资讯

Le Lézard6 天
ImmunityBio to Showcase Advances for Bladder and Prostate Cancer at American Urological ...
ImmunityBio, Inc. , a leading immunotherapy company, will announce new clinical findings for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in non-muscle invasive bladder cancer carcinoma in situ (NMIBC ...